- US-listed companies
- Citius Pharmaceuticals, Inc.
- Balance sheet
Citius Pharmaceuticals, Inc.CTXR
Market cap
$10.7M
P/E ratio
| 2011/09 | 2012/09 | 2013/09 | 2015/09 | 2016/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
| Cash and cash equivalents | 212 | 135 | - | 676,137 | 294,351 | 9 | 8 | 14 | 70 | 42 | 26 | 3 |
| Total cash & short-term investments | 212 | 135 | - | 676,137 | 294,351 | 9 | 8 | 14 | 70 | 42 | 26 | 3 |
| Total current assets | 212 | 135 | - | 736,137 | 892,835 | 10 | 8 | 14 | 73 | 45 | 34 | 14 |
| Property, plant and equipment, net | - | - | - | - | 3,742 | 1,483 | 590 | 1,577 | 7,023 | 4,100 | 1,432 | - |
| Total non-current assets | - | - | - | 5,401 | 21 | 21 | 21 | 30 | 70 | 69 | 69 | 102 |
| Total assets | 212 | 135 | - | 741,538 | 22 | 31 | 29 | 44 | 142 | 114 | 104 | 117 |
| Accounts payable | 906 | - | 11,474 | 559,150 | 909,156 | 2 | 3 | 2 | 1 | 1 | 3 | 5 |
| Total current liabilities | 24,053 | 45,982 | 14,694 | 1 | 5 | 3 | 5 | 4 | 4 | 5 | 6 | 36 |
| Total non-current liabilities | - | - | - | - | - | - | - | 6 | 6 | 6 | 6 | 7 |
| Total liabilities | - | - | - | - | - | - | - | 10 | 10 | 11 | 12 | 43 |
| Common stock and paid-in capital | 18,000 | 18,000 | 80,522 | 8 | 34 | 68 | 80 | 104 | 228 | 233 | 253 | 271 |
| Retained earnings | - | - | - | -9,040,549 | -17,336,247 | -40,257,838 | -55,819,982 | -70,593,867 | -96,047,821 | -129,688,467 | -162,231,379 | -201,370,218 |
| Stockholders' equity | -23,841 | -45,847 | -14,694 | -635,213 | 17 | 28 | 24 | 34 | 133 | 103 | 91 | 74 |